ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,921,400 | -54.6% | 623,434 | -22.1% | 0.08% | -63.4% |
| Q3 2022 | $8,640,000 | -5.3% | 800,000 | 0.0% | 0.23% | +16.4% |
| Q2 2022 | $9,120,000 | +25.1% | 800,000 | 0.0% | 0.20% | +28.3% |
| Q1 2022 | $7,288,000 | -38.9% | 800,000 | 0.0% | 0.15% | -17.4% |
| Q4 2021 | $11,936,000 | -41.9% | 800,000 | 0.0% | 0.18% | -31.6% |
| Q3 2021 | $20,560,000 | -1.5% | 800,000 | 0.0% | 0.27% | +25.1% |
| Q2 2021 | $20,864,000 | -26.1% | 800,000 | 0.0% | 0.22% | -22.9% |
| Q1 2021 | $28,240,000 | +39.9% | 800,000 | 0.0% | 0.28% | +73.3% |
| Q4 2020 | $20,192,000 | -33.1% | 800,000 | 0.0% | 0.16% | -29.7% |
| Q3 2020 | $30,168,000 | -11.9% | 800,000 | 0.0% | 0.23% | -26.8% |
| Q2 2020 | $34,256,000 | – | 800,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |